Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.

ABSTRACT:

SUBMITTER: Ayaz S 

PROVIDER: S-EPMC7491010 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature